Trump Nominates Dr. Erica Schwartz for CDC Director

President Donald Trump has nominated Dr. Erica Schwartz to serve as the Director of the Centers for Disease Control and Prevention (CDC), ending a prolonged period of temporary leadership at the nation’s top public health agency. The announcement was made via a post on Truth Social on April 16, 2026, where Trump praised Schwartz as an “incredibly talented” leader with the expertise to restore what he described as the “GOLD STANDARD OF SCIENCE” at the CDC.

Schwartz, a rear admiral in the U.S. Public Health Service Commissioned Corps and former deputy surgeon general during Trump’s first term, brings extensive experience in military and public health leadership. She earned her medical degree from Brown University and holds both a master’s in public health and a law degree from the University of Maryland. Her career includes service in the U.S. Navy until 2005, followed by work with the Coast Guard, where she oversaw health operations during crises such as the Deepwater Horizon oil spill and served as chief medical officer for the branch.

In her role with the Coast Guard, Schwartz developed pandemic influenza policies and managed a network of 41 clinics and 150 sick bays. She also played a part in anthrax and smallpox vaccination initiatives and responded to the Ebola crisis. Her leadership during public health emergencies has been highlighted by former Surgeon General Dr. Jerome Adams, who praised her as a “battle-tested leader” with the credibility to guide the CDC effectively if permitted to follow scientific guidance without political interference.

The nomination comes after nearly eight months without a Senate-confirmed CDC director. Leadership at the agency has been unstable during Trump’s second term, beginning with the withdrawal of Dr. David Weldon as the administration’s initial nominee due to concerns over his likelihood of Senate confirmation. Dr. Susan Monarez was subsequently confirmed in July 2025 but served less than a month before being removed after disagreeing with Health and Human Services Secretary Robert F. Kennedy Jr. Over vaccine policy changes, including efforts to dismiss vaccine officials without cause and alter immunization recommendations without scientific basis.

Kennedy has since implemented sweeping changes to national childhood vaccine guidelines, including removing annual flu and COVID-19 shot requirements for most children. These changes were blocked by a federal judge in March 2026, who stayed the modifications pending legal review. Kennedy also disbanded the CDC’s independent Advisory Committee on Immunization Practices, replacing its expert members with individuals holding more vaccine-skeptical views.

Amid a nationwide measles outbreak and ahead of the 2026 midterm elections, Kennedy has reportedly softened his public stance on vaccines following White House guidance, according to The Wall Street Journal. In response to the nomination, Dr. Adams expressed cautious optimism, stating he was “encouraged by this pick” and hopeful that Schwartz could lead the agency based on evidence rather than political pressure.

If confirmed by the Senate, Schwartz would succeed Dr. Jay Bhattacharya of the National Institutes of Health, who has served as acting CDC director since February 2026. Trump also announced companion nominations: Sean Slovenski as deputy director and chief operating officer, Dr. Jennifer Shuford as deputy director and chief medical officer, and Dr. Sara Brenner as senior counselor for public health to Secretary Kennedy.